18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
about
A Novel SCCA Approach via Truncated ℓ1-norm and Truncated Group Lasso for Brain Imaging Genetics.Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.Amyloid pathology in the progression to mild cognitive impairment.NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Molecular biomarkers of Alzheimer's disease: progress and prospects.Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology.The development and validation of tau PET tracers: current status and future directions
P2860
Q47316860-7DBF75A4-E8FE-47B9-9E3D-E7F1F41167A0Q47604596-A53408E9-5FAD-4008-A08A-AEFBAA1567E3Q47651177-D650FE91-CAF6-4F90-8B99-2C1D96F9EE98Q52589491-925C85BD-3829-4C4F-BF61-405E36A753D3Q54946040-97399DC9-6FB5-42A9-8342-416CE44AFC4CQ55003313-B830E306-8C3A-4B90-A13D-8C9E27877CD2Q56594907-0A389DD8-ABCF-47E0-BD61-CBDE9DC602A4
P2860
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
@en
type
label
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
@en
prefLabel
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
@en
P2093
P2860
P50
P356
P1476
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
@en
P2093
Douglas Hägerström
Jonas Jögi
Michael Schöll
Olof Strandberg
Philip S Insel
Ruben Smith
Sebastian Palmqvist
Tomas Ohlsson
P2860
P304
P356
10.15252/EMMM.201707809
P577
2017-07-25T00:00:00Z